Connor, Clark & Lunn Investment Management Ltd. Otonomy, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$3.48 - $6.47 $47,415 - $88,153
-13,625 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$3.16 - $4.36 $27,390 - $37,792
-8,668 Reduced 38.88%
13,625 $55,000
Q2 2020

Aug 13, 2020
SELL
$1.87 - $3.84 $15,863 - $32,574
-8,483 Reduced 27.56%
22,293 $81,000
Q1 2020

May 13, 2020
BUY
$1.58 - $4.06 $48,626 - $124,950
30,776 New
30,776 $60,000
Q3 2019

Nov 13, 2019
SELL
$2.12 - $2.86 $30,528 - $41,184
-14,400 Closed
0 $0
Q2 2019

Aug 07, 2019
SELL
$2.35 - $3.09 $25,850 - $33,990
-11,000 Reduced 43.31%
14,400 $40,000
Q1 2019

May 08, 2019
SELL
$1.8 - $2.97 $16,560 - $27,324
-9,200 Reduced 26.59%
25,400 $67,000
Q4 2018

Feb 12, 2019
SELL
$1.51 - $2.93 $19,358 - $37,562
-12,820 Reduced 27.04%
34,600 $64,000
Q3 2018

Nov 13, 2018
BUY
$2.6 - $3.95 $8,320 - $12,640
3,200 Added 7.24%
47,420 $130,000
Q2 2018

Aug 02, 2018
BUY
$3.7 - $4.75 $38,298 - $49,167
10,351 Added 30.56%
44,220 $170,000
Q1 2018

May 14, 2018
BUY
$4.05 - $6.1 $88,695 - $133,590
21,900 Added 182.97%
33,869 $142,000
Q4 2017

Feb 09, 2018
BUY
$2.8 - $5.55 $33,513 - $66,427
11,969
11,969 $66,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email